XGN - EXAGEN INC.
IEX Last Trade
2.79
0 0%
Share volume: 30,650
Last Updated: Tue 24 Dec 2024 03:25:34 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.45%
PREVIOUS CLOSE
CHG
CHG%
$2.79
2.26
0.45%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-11-21 | 2022-11-21 | 2023-03-20 | 2023-05-15 | 2023-08-07 | 2023-11-13 | 2024-03-18 | 2024-05-13 | |
| Total revenue | 7.606 M | 14.726 M | 12.837 M | 11.230 M | 14.137 M | 13.416 M | 13.765 M | 14.415 M | |
| Cost of revenue | 6.078 M | 6.010 M | 6.309 M | 5.926 M | 5.836 M | 5.710 M | 5.620 M | 5.817 M | |
| Gross profit | 1.528 M | 8.716 M | 6.528 M | 5.304 M | 8.301 M | 7.706 M | 8.145 M | 8.598 M | |
| 470.42% | -25.10% | -18.75% | 56.50% | -7.17% | 5.70% | 5.56% | |||
| Operating expenses | 15.592 M | 16.533 M | 15.513 M | 13.010 M | 13.216 M | 12.775 M | 13.292 M | 11.601 M | |
| Selling general and admin | 12.903 M | 14.151 M | 12.812 M | 11.884 M | 11.953 M | 11.375 M | 12.216 M | 10.542 M | |
| Research and development | 2.689 M | 2.382 M | 2.701 M | 1.126 M | 1.263 M | 1.400 M | 1.076 M | 1.059 M | |
| Total expenses | 21.670 M | 22.543 M | 21.822 M | 18.936 M | 19.052 M | 18.485 M | 18.912 M | 17.418 M | |
| 4.03% | -3.20% | -13.23% | 0.61% | -2.98% | 2.31% | -7.90% | |||
| Operating income | -14.064 M | -7.817 M | -8.985 M | -7.706 M | -4.915 M | -5.069 M | -5.147 M | -3.003 M | |
| Ebit | -14.064 M | -7.817 M | -8.985 M | -7.706 M | -4.915 M | -5.069 M | -5.147 M | -3.003 M | |
| Pretax income | -14.665 M | -8.096 M | -14.636 M | -7.688 M | -5.013 M | -5.415 M | -5.540 M | -3.360 M | |
| -44.79% | 80.78% | -47.47% | -34.79% | 8.02% | 2.31% | -39.35% | |||
| Income tax | 0.000 | 0.000 | -282.000 K | 0.000 | 0.000 | 0.000 | 33.000 K | 0.000 | |
| Net income basic | -14.665 M | -8.096 M | -14.354 M | -7.688 M | -5.013 M | -5.415 M | -5.573 M | -3.360 M | |
| 44.79% | -77.30% | 46.44% | 34.79% | -8.02% | -2.92% | 39.71% | |||
| Net income | -14.665 M | -8.096 M | -14.354 M | -7.688 M | -5.013 M | -5.415 M | -5.573 M | -3.360 M | |
| 44.79% | -77.30% | 46.44% | 34.79% | -8.02% | -2.92% | 39.71% |